CD274 and non-small cell lung carcinoma: The hypothesis-generating findings highlight PD-L1<sup>+</sup> macrophages in the TME and classical monocytes in the blood as potential immune biomarkers of RT response, but larger studies are needed to validate these observations and characterize the immune changes following curative-intent RT in patients with NSCLC.